Grødeland G - Search Results

1

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study.

Bjørlykke KH, Ørbo HS, Tveter AT, Jyssum I, Sexton J, Tran TT, Christensen IE, Kro GB, Kvien TK, Jahnsen J, Munthe LA, Chopra A, Warren DJ, Mjaaland S, Haavardsholm EA, Grødeland G, Provan SA, Vaage JT, Syversen SW, Goll GL, Jørgensen KK. Bjørlykke KH, et al. Among authors: grodeland g. Lancet Rheumatol. 2023 Jan;5(1):e36-e46. doi: 10.1016/S2665-9913(22)00330-7. Epub 2022 Nov 16. Lancet Rheumatol. 2023. PMID: 36415604 Free PMC article.

2

[The vaccines can keep up with the SARS-CoV-2 mutations].

Andersen TK, Grødeland G. Andersen TK, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2021 Feb 1;141(3). doi: 10.4045/tidsskr.21.0080. Print 2021 Feb 23. Tidsskr Nor Laegeforen. 2021. PMID: 33624975 Free article. Norwegian. No abstract available.

3

Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro.

Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD. Huang TS, et al. Among authors: grodeland g. Chronobiol Int. 2009 Feb;26(2):242-57. doi: 10.1080/07420520902766025. Chronobiol Int. 2009. PMID: 19212839

4

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines.

Ruffini PA, Grødeland G, Fredriksen AB, Bogen B. Ruffini PA, et al. Among authors: grodeland g. Vaccine. 2010 Dec 16;29(2):191-9. doi: 10.1016/j.vaccine.2010.10.057. Epub 2010 Nov 4. Vaccine. 2010. PMID: 21055498

5

[Efficacy of three doses of COVID-19 vaccine].

Vaksdal HH, Grødeland G. Vaksdal HH, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2022 Feb 18;142(5). doi: 10.4045/tidsskr.22.0096. Print 2022 Mar 22. Tidsskr Nor Laegeforen. 2022. PMID: 35324133 Free article. Norwegian. No abstract available.

6

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Grodeland G, Fredriksen AB, Løset GÅ, Vikse E, Fugger L, Bogen B. Grodeland G, et al. J Immunol. 2016 Nov 1;197(9):3575-3585. doi: 10.4049/jimmunol.1600893. Epub 2016 Sep 26. J Immunol. 2016. PMID: 27671110 Free PMC article.

7

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.

Mooij P, Grødeland G, Koopman G, Andersen TK, Mortier D, Nieuwenhuis IG, Verschoor EJ, Fagrouch Z, Bogers WM, Bogen B. Mooij P, et al. Among authors: grodeland g. Vaccine. 2019 Feb 4;37(6):817-826. doi: 10.1016/j.vaccine.2018.12.049. Epub 2019 Jan 9. Vaccine. 2019. PMID: 30638800 Free article.

8

DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.

Grodeland G, Mjaaland S, Roux KH, Fredriksen AB, Bogen B. Grodeland G, et al. J Immunol. 2013 Sep 15;191(6):3221-31. doi: 10.4049/jimmunol.1300504. Epub 2013 Aug 16. J Immunol. 2013. PMID: 23956431 Free PMC article.

9

The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype.

Grødeland G, Mjaaland S, Tunheim G, Fredriksen AB, Bogen B. Grødeland G, et al. PLoS One. 2013 Nov 11;8(11):e80008. doi: 10.1371/journal.pone.0080008. eCollection 2013. PLoS One. 2013. PMID: 24244595 Free PMC article.

10

Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.

Fossum E, Grødeland G, Terhorst D, Tveita AA, Vikse E, Mjaaland S, Henri S, Malissen B, Bogen B. Fossum E, et al. Among authors: grodeland g. Eur J Immunol. 2015 Feb;45(2):624-35. doi: 10.1002/eji.201445080. Epub 2014 Dec 28. Eur J Immunol. 2015. PMID: 25410055 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page